News

ChoiceOne Bank Honored with 2023 Lender of the Year Recognition

ChoiceOne Bank Honored with 2023 Lender of the Year Recognition

ChoiceOne Bank Earns Esteemed 2023 Lender of the Year Award

ChoiceOne Financial Services, Inc., along with its banking branch, ChoiceOne Bank (NASDAQ: COFS), has been honored by the Michigan Certified Development Corporation (MCDC) as the 2023 Lender of the Year. This accolade reflects the bank's steadfast commitment to fostering economic growth in local communities by supporting small business financing.

Recognizing Individual Accomplishments

In addition to the bank's overall recognition, Bradley Bissett, who serves as Vice President and Commercial Loan Officer at ChoiceOne, was awarded the MCDC 2023 Individual Lender of the Year. This recognition underscores the significant impact individual contributions make within the lending industry, highlighting ChoiceOne's dedication to delivering excellent service.

A Focus on Community Development

Bradley Henion, the Executive Vice President and Chief Lending Officer at ChoiceOne, spoke proudly of the bank's achievements, stating, "Receiving the MCDC 2023 Lender of the Year Award is a testament to Aaron Griffin's hard work and dedication. Our mission has always been to cultivate strong relationships with entrepreneurs and small business owners while promoting business growth and economic development in our communities."

Understanding the Role of SBA Loans

In today's competitive landscape, the SBA 504 loan program stands out as a crucial resource for business owners aiming to expand. Unlike conventional loans, the SBA 504 loan is backed by the government, which allows borrowers access to more favorable terms to help them grow their operations and invest in essential resources.

Customized Solutions for Local Businesses

Eric Kehler, Vice President of SBA 504 Lending at MCDC, praised ChoiceOne for its impressive performance as a top lending partner. He noted their client-focused approach and innovative lending solutions. ChoiceOne's success in the 2023 SBA 504 Loan Program showcases their in-depth understanding of what borrowers need, setting a high standard in the industry.

Highlighting Bradley Bissett’s Contributions

Since joining ChoiceOne in 2022, Bissett has made exceptional contributions, drawing on nearly 20 years of experience in commercial lending. He has held key positions, including that of Chief Credit Officer, which equips him to make savvy decisions that benefit clients. His educational credentials from Central Michigan University and further training at the Graduate School of Banking in Madison, Wisconsin, emphasize his expertise.

Community Engagement and Contribution

Apart from his professional duties, Bissett actively gives back by engaging in local economic development efforts and volunteering for youth sports initiatives. His commitment to building relationships extends beyond banking, promoting a well-rounded approach to community service.

The Effects of ChoiceOne’s Lending Initiatives

Aaron Griffin pointed out that ChoiceOne’s mission revolves around understanding the specific challenges faced by small businesses. The bank's SBA 504 loan program, which offers long-term, fixed-rate financing for significant assets, has been instrumental in helping many customers obtain the necessary resources for growth. In 2023, ChoiceOne Bank received acknowledgment as the community bank with the highest volume of SBA 504 loans processed with MCDC.

Success That Goes Beyond Awards

This year, the bank was also honored as the SBA Michigan District 504 Third-Party Lender of the Year, further cementing its role as a reliable financial ally for small businesses. With a total of seven SBA 504 loans reaching nearly $7 million, ChoiceOne remains dedicated to supporting the local economy.

About the Michigan Certified Development Corporation

Founded in 1982, MCDC has established itself as the leading partner for facilitating SBA loans throughout Michigan, aiding thousands of small businesses in obtaining financial support to achieve their growth objectives. Their mission focuses on driving economic development and job creation across the state.

About ChoiceOne Financial Services

ChoiceOne Financial Services, Inc. is headquartered in Sparta, Michigan, and is a well-regarded financial holding company. With 35 branches spanning multiple counties, it has made a significant mark in the Michigan banking sector. Through its subsidiary, ChoiceOne Insurance Agencies, Inc., the company offers not just banking services but also insurance and investment options.

Frequently Asked Questions

What award did ChoiceOne Bank receive in 2023?

ChoiceOne Bank was honored with the MCDC 2023 Lender of the Year Award.

Who was recognized as the Individual Lender of the Year?

Bradley Bissett received the MCDC 2023 Individual Lender of the Year award.

What is the SBA 504 loan?

The SBA 504 loan is a government-backed financial product designed to help small businesses acquire fixed assets and expand operations.

What are some community contributions of Bradley Bissett?

Bradley Bissett is active in local economic development and volunteers in children's sports programs.

How many SBA 504 loans did ChoiceOne complete in 2023?

ChoiceOne Bank completed seven SBA 504 loans, amounting to nearly $7 million in total financing.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading